A Dark Vector Cognition product

Item 5. Other Information

6K characters. Original on sec.gov ·

Item 5. Other Information

The 3 tables in Item 5. Other Information as one CSV, figures in aligned columns. For subscribers: paste your API key. One API call. Plans from $19 a month, see pricing.

Rule 10b5-1 Trading Plans

In accordance with the disclosure requirement set forth in Item 408(a) of Regulation S-K, the following table discloses the officers (as defined in Rule 16a-1(f) under the Exchange Act) and directors who adopted a contract, instruction or written plan for the sale of the Company’s securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) during the quarter ended September 30, 2026. These trading plans were adopted during an open trading window.

Name / TitleType of PlanAdoption DateEnd DateAggregate Number of Securities to be SoldPlan Description
Jonathan Banner / EVP – Global Chief Impact OfficerRule 10b5-1 trading planAugust 10, 2026November 30, 20261,500Sale of shares
Morgan Flatley / EVP – Global Chief Marketing OfficerRule 10b5-1 trading planAugust 18, 2026November 16, 202712,651[1]Sale of shares
Desiree Ralls-Morrison / EVP – Global Chief Legal OfficerRule 10b5-1 trading planAugust 28, 2026December 31, 202725,416[2]Sale of shares, and exercise and sale of stock options

[1] Represents 4,291 vested shares and a maximum of 8,360 shares that are eligible to vest pursuant to Ms. Flatley's 2024 performance-based restricted stock unit ("PRSU") award. The actual number of shares that will vest under Ms. Flatley's 2024 PRSU award will depend upon the Company's performance against certain pre-established targets and will determine the number of shares that may ultimately be sold pursuant to the trading plan.

[2] Represents 16,892 vested shares and a maximum of 8,524 shares that are eligible to vest pursuant to Ms. Ralls-Morrison's 2024 PRSU award. The actual number of shares that will vest under Ms. Ralls-Morrison's 2024 PRSU award will depend upon the Company's performance against certain pre-established targets and will determine the number of shares that may ultimately be sold pursuant to the trading plan.

Other than as disclosed above, no officer or director adopted, modified, or terminated a contract, instruction or written plan for the purchase or sale of the Company’s securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or a non-Rule 10b5-1 trading arrangement.

Item 6. Exhibits
Exhibit No.Description
(31.1)Rule 13a-14(a) Certification of Chief Executive Officer.
(31.2)Rule 13a-14(a) Certification of Chief Financial Officer.
(32.1)Certification pursuant to 18 U.S.C. Section 1350 by the Chief Executive Officer, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
(32.2)Certification pursuant to 18 U.S.C. Section 1350 by the Chief Financial Officer, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
(101.INS)XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
(101.SCH)Inline XBRL Taxonomy Extension Schema Document.
(101.CAL)Inline XBRL Taxonomy Extension Calculation Linkbase Document.
(101.DEF)Inline XBRL Taxonomy Extension Definition Linkbase Document.
(101.LAB)Inline XBRL Taxonomy Extension Label Linkbase Document.
(101.PRE)Inline XBRL Taxonomy Extension Presentation Linkbase Document.
(104)Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

McDONALD’S CORPORATION (Registrant)
/s/ Ian F. Borden
Date:November 6, 2026Ian F. Borden
Executive Vice President and Global Chief Financial Officer

Previous: Item 1A. Risk Factors